Back
Fulcrum Therapeutics Stock Price Chart
10 Stellar Stocks - get the names here
Learn their names here. FREE
Sell
24
FULC
Fulcrum Therapeutics
Last Price:
$3.69
Seasonality Move:
-28.47%
7 Day Trial
ALL ACCESS PASS
$
7
Apple's Space Move Could Send This Pre-IPO Stock Soaring
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing selling pressure, which indicates risk of future bearish movement.
Fulcrum Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.68 | Buy |
| 20-day SMA: | 3.89 | Sell |
| 50-day SMA: | 4.16 | Sell |
| 200-day SMA: | 5.75 | Sell |
| 8-day EMA: | 3.7 | Sell |
| 20-day EMA: | 3.87 | Sell |
| 50-day EMA: | 4.03 | Sell |
| 200-day EMA: | 5.19 | Sell |
Fulcrum Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 41.55 | Sell |
| Chaikin Money Flow: | -498263 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.72 - 4.16) | Sell |
| Bollinger Bands (100): | (3.31 - 4.29) | Sell |
Fulcrum Therapeutics Technical Analysis
| Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Fulcrum Therapeutics Stock
Is Fulcrum Therapeutics Stock a Buy?
-
Fulcrum Therapeutics share price is 3.69 while FULC 8-day simple moving average is 3.68, which is a Buy signal.
-
The stock price of FULC is 3.69 while Fulcrum Therapeutics 20-day SMA is 3.89, which makes it a Sell.
-
Fulcrum Therapeutics 50-day simple moving average is 4.16 while FULC share price is 3.69, making it a Sell technically.
-
FULC stock price is 3.69 and Fulcrum Therapeutics 200-day simple moving average is 5.75, creating a Sell signal.
FULC Technical Analysis vs Fundamental Analysis
Sell
24
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy or a Sell?
-
Fulcrum Therapeutics stock is rated a SellThe current Fulcrum Therapeutics [FULC] share price is $3.69. The Score for FULC is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Fulcrum Therapeutics Stock Info
Market Cap:
199M
Price in USD:
3.69
Share Volume:
848.4K
Fulcrum Therapeutics 52-Week Range
52-Week High:
13.70
52-Week Low:
2.86
Sell
24
Fulcrum Therapeutics (FULC)
is a Sell
Fulcrum Therapeutics Share Price Forecast
-
What is the Fulcrum Therapeutics stock price today?The Fulcrum Therapeutics stock price is 3.69 USD today.
-
Will FULC stock go up or go down?Fulcrum Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Fulcrum Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Fulcrum Therapeutics is overvalued.
Is Fulcrum Therapeutics Stock a Buy?
-
Fulcrum Therapeutics share price is 3.69 while FULC 8-day exponential moving average is 3.70, which is a Sell signal.
-
The stock price of FULC is 3.69 while Fulcrum Therapeutics 20-day EMA is 3.87, which makes it a Sell.
-
Fulcrum Therapeutics 50-day exponential moving average is 4.03 while FULC share price is 3.69, making it a Sell technically.
-
FULC stock price is 3.69 and Fulcrum Therapeutics 200-day simple moving average is 5.19, creating a Sell signal.
Fundamental Analysis of Fulcrum Therapeutics
Is Fulcrum Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and a decrease next year of $0.07 per share.
Technical Analysis of Fulcrum Therapeutics
Should I short Fulcrum Therapeutics stock?
-
FULC Moving Average Covergence Divergence (MACD) indicator is -0.16, suggesting Fulcrum Therapeutics is a Sell
-
Fulcrum Therapeutics Relative Strength Index (RSI) is 41.55, which suggest Fulcrum Therapeutics is oversold
-
The Bollinger Bands (25) for Fulcrum Therapeutics is (3.72 - 4.16), which suggest Fulcrum Therapeutics is a Sell
-
The Bollinger Bands (100) for Fulcrum Therapeutics is (3.31 - 4.29), which suggest Fulcrum Therapeutics is a Sell
* Fulcrum Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.